Metamucil Fibre Therapy Clear Fibre Blend
Metamucil Fibre Therapy Clear Fibre Blend, NPN 80142618: natural health product licensed in Canada. Medicinal ingredients: Maltodextrines résistantes.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Maltodextrines résistantes Source : Zea mays - Graine Potency : 2.45 g Fiber | 2.72 g | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Portions | 3 Tous les jours |
Uses authorised in Canada
Source of fibre for the maintenance of good health. Helps support and maintain a healthy digestive system. Helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine/gut. Prebiotic. Helps provide gentle relief of constipation and/or irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Known Adverse Reactions
Stop use and ask a health care professional if hypersensitivity/allergy occurs. When using this product you may experience temporary gas and bloating.
- Cautions and Warnings
Ask a health care professional if - you have diabetes or are taking any prescription medications - you are pregnant/breastfeeding - symptoms worsen or if laxative effect does not occur within 7 days - you are taking medications which inhibit peristaltic movement. Ask a health care professional you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of other serious conditions) - you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product. Keep out of reach of children.
- Contra-Indications
Do not use if you have fever or any undiagnosed gastrointestinal trouble.
Product record
- Other names
- Metamucil Clear Fibre Blend, Metamucil Fibre Blend
- Licence holder
- Procter & Gamble Inc.
- NPN or DIN-HM
- 80142618
- Status
- Active licence
- Licence date
- 15 July 2025
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80142618
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Metamucil Fibre Therapy Clear Fibre Blend (Procter & Gamble Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80142618-metamucil-fibre-therapy-clear-fibre-blend, updated 15 July 2025.